Aiken M, Ciaglowski R E, Walz D A
Arch Biochem Biophys. 1986 Oct;250(1):257-62. doi: 10.1016/0003-9861(86)90724-1.
Bovine freeze-thaw lysed platelets were fractionated by dextran sulfate affinity chromatography and a purified protein of 23,000 Da was subsequently obtained by G-75 gel filtration of the 0.5 M NaCl fraction. This protein had an amino terminal sequence of Asn-Arg-Ile-Pro-Glu-Ser-Gly-Gly-Asp-Asn-Ser-Val-Phe-Asp-Ile-Phe-Glu-Leu- Thr-Gly-Ala-Ala-Trp-Lys-, a sequence identical to that reported for human thrombospondin. Thrombin-released platelets, fractionated in an identical manner, yielded a protein of 30,000 Da. Immunoblotting of purified bovine platelet thrombospondin and the 150,000- and 30,000-Da plasmin-generated thrombospondin fragments indicated that polyclonal antisera raised against the 23,000-Da protein cross-reacted with intact thrombospondin and the 30,000-Da fragment but not the 150,000-Da fragment. The 23,000-Da protein possessed weak heparin neutralization activity.
将牛冻融裂解的血小板通过硫酸葡聚糖亲和层析进行分级分离,随后对0.5M NaCl组分进行G-75凝胶过滤,得到了一种23,000道尔顿的纯化蛋白。该蛋白的氨基末端序列为Asn-Arg-Ile-Pro-Glu-Ser-Gly-Gly-Asp-Asn-Ser-Val-Phe-Asp-Ile-Phe-Glu-Leu-Thr-Gly-Ala-Ala-Trp-Lys-,与报道的人血小板反应蛋白的序列相同。以相同方式分级分离的凝血酶释放血小板产生了一种30,000道尔顿的蛋白。对纯化的牛血小板反应蛋白以及150,000和30,000道尔顿的纤溶酶生成的血小板反应蛋白片段进行免疫印迹分析表明,针对23,000道尔顿蛋白产生的多克隆抗血清与完整的血小板反应蛋白和30,000道尔顿片段发生交叉反应,但不与150,000道尔顿片段发生交叉反应。23,000道尔顿的蛋白具有较弱的肝素中和活性。